Network Medicine Alliance
The Network Medicine Alliance (NMA) represents 33 leading universities and institutions around the world committed to improving global health and advancing the field of Network Medicine. NMA’s mission is to facilitate interdisciplinary research combining principles and approaches from network sciences, systems biology, and human dynamics to understand the causes of human diseases and develop new treatments. NMA also provides leverage for influencing global health policy and clinical guidelines.
EXECUTIVE TEAM
Prof. Joseph Loscalzo
NMA Founder and Scientific Committee Chair
NMI Chairman, Hersey Professor of the Theory and Practice of Medicine at Harvard University, Soma Weiss M.D., Distinguished Chair in Medicine Harvard Medical School, Chairman of the Department of Medicine, and Physician-in-Chief at Brigham and Women’s Hospital, Harvard University, USA
Prof. Albert-LaszLo BarAbasi
NMA Cofounder
Robert Gray Dodge Professor of Network Science, Distinguished University Professor, Director of Center for Complex Network Research, Northeastern University, USA
ENRICO PETRILLO, MD
NMA Cofounder and Executive Director
Advisor to the Chairman, Dept. of Medicine, and Physician–in–Chief for International Research, Lead Investigator at Brigham and Women’s Hospital Division of General Internal Medicine, Lecturer Harvard Medical School, Harvard University, faculty researcher at Karolinska Institute, Sweden.
goals
The alliance’s primary goal is to promote interdisciplinary research among alliance members and their respective schools (eg. medicine, life sciences, computer science, physical sciences), institutes, medical centers, and research centers.
The traditions of excellence at Brigham and Women’s Hospital and premier International Universities and academic medical centers provide the basis for developing joint programs in biomedicine. These programs will increase the quality of academic contributions and enhance the international reputations of our alliance members.
impact
The Network Medicine Alliance will help untap the full potential of personalized medicine.
It will establish a multinational patient registry in a format conducive to analysis using state-of-the-art Network Science and Artificial Intelligence techniques.
This will enable researches to examine which contributing biological and environmental factors are protective or detrimental to an individual's disease response.
And by expanding registry access to multinational research collaborations with public and private institutions, there is opportunity to influence global health policy and update clinical guidelines to lessen the health and socioeconomic burden on society.
Strategy
The alliance will focus its efforts in four areas:
(1) Clinical Care
(2) Education
(3) Research and
(4) Innovation.
Clinical Care
We support the Clinical Care in three ways.
The first is a faculty exchange program that will help faculty with common interests explore research opportunities at other institutions.
Second, we will develop a clinical care exchange program. This enables clinicians to diversify their experience and exposes them to alternate ways of diagnosing and managing patients.
Third, we will have a formal telemedicine program. It will provide opportunities (virtually) for teams of physicians or physician-scientists at participating institutions to assess complex patients together.
education
We developed a formal exchange program for clinicians, researchers, and academic physicians. These exchange programs can range from one week to one year in duration, and should have a clear goal and purpose that would advance the career development of the individual.
research
We will develop collaborative research programs. They will involve interdisciplinary programs that extend beyond the scope of conventional biomedical scientists and be funded by a myriad of governmental, private and foundation sources.
These programs will serve as a foundation upon which deeper collaborations can grow.
Innovation
The resources and attention supporting the clinical care, education, and research programs will translate to better patient care, new perspectives on health policy, and updated clinical guidelines.
These programs will also give rise to additional funding opportunities with further potential to advance the field of Network Medicine.